Concept
Risk of seropositivity across demographics: Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
Risk of seropositivity across demographics
- Comparable across gender (RR 1.26 [95% CI 1.00–1.58])
- Age: 5-9 years and 65+ were lower than 20-49 years, RR 0.32 (0.11–0.63) and RR 0.5 (0.28-0.78), respectively
- 17.1% of children 5-9 had one or more seropositive family member
- 3% of adults 65+ had a seropositive family member
0
1
Updated 2020-06-19
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Risk of seropositivity across demographics: Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
Table 2: Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
Figure: Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study